HIV-infected persons have an increased incidence of emphysema compared to those without HIV infection, and it has been hypothesized that this accelerated disease progression is the result of one or more latent infectious agents that amplify the pulmonary inflammatory response to cigarette smoke. Pneumocystis jirovecii (formerly Pneumocystis carinii, f. sp. Hominis) is one infectious agent that likely plays a key role in the development of HIV-infected smokers are particularly susceptible to Pneumocystis colonization regardless of CD4 cell count or use of prophylaxis. Pneumocystis colonization is also increased in non-HIV-infected patients with chronic obstructive pulmonary disease (COPD) and is directly related to the severity of the disease. The presence of Pneumocystis in the lungs, even at low levels as seen in colonization, produces inflammatory changes similar to those seen in COPD, with increases in the numbers of neutrophils and cytotoxic CD8+ lymphocytes. We hypothesize that Pneumocystis accelerates emphysema in HIV-infected smokers by stimulating inflammation and tissue destruction. We will explore this theory by completing the following specific aims: 1) Testing the hypothesis that Pneumocystis colonization contributes to HIV-associated emphysema by stimulating pulmonary inflammation and release of proteases. 2) Testing the role of Pneumocystis colonization in accelerating progression of physiologic obstruction or the anatomic airway and parenchymal changes associated with emphysema in HIV-infected patients. 3) Testing the effects of treatment of Pneumocystis colonization on decreasing inflammation and protease activity. We will study a cohort of HIV-infected smokers and non-smokers and perform detailed analyses of pulmonary inflammation and Pc colonization which will be correlated to functional outcomes of pulmonary physiology and therapy of HIV-associated emphysema and provide a model for emphysema in the general population. Public health significance: This proposal will explain why HIV-infected individuals develop emphysema faster than non-HIV-infected people. This information will help us understand and treat emphysema in these patients and in the many non-HIV-infected people who suffer from this disease.
| Li, Yijia; Nouraie, Seyed Mehdi; Kessinger, Cathy et al. (2018) Factors Associated With Progression of Lung Function Abnormalities in HIV-Infected Individuals. J Acquir Immune Defic Syndr 79:501-509 |
| Morris, Alison; Fitzpatrick, Meghan; Bertolet, Marnie et al. (2017) Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease. AIDS 31:539-544 |
| Barton, Julia H; Ireland, Alex; Fitzpatrick, Meghan et al. (2016) Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study. BMC Pulm Med 16:111 |
| Simon, Marc A; Lacomis, Christopher D; George, M Patricia et al. (2014) Isolated right ventricular dysfunction in patients with human immunodeficiency virus. J Card Fail 20:414-421 |
| Gingo, Matthew R; Balasubramani, Goundappa K; Rice, Thomas B et al. (2014) Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts. BMC Pulm Med 14:75 |
| Fitzpatrick, Meghan E; Singh, Vikas; Bertolet, Marnie et al. (2014) Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort. AIDS 28:2505-15 |
| Gingo, Matthew R; He, Jiayan; Wittman, Catherine et al. (2014) Contributors to diffusion impairment in HIV-infected persons. Eur Respir J 43:195-203 |
| Morris, Alison (2014) Heart-lung interaction via infection. Ann Am Thorac Soc 11 Suppl 1:S52-6 |
| Clausen, Emily; Wittman, Catherine; Gingo, Matthew et al. (2014) Chest computed tomography findings in HIV-infected individuals in the era of antiretroviral therapy. PLoS One 9:e112237 |
| Gingo, Matthew R; Morris, Alison; Crothers, Kristina (2013) Human immunodeficiency virus-associated obstructive lung diseases. Clin Chest Med 34:273-82 |
Showing the most recent 10 out of 30 publications
